Le Lézard
Classified in: Covid-19 virus
Subject: SVY

Insights on the Biomaterials Global Market to 2025 - Forecast and Opportunities


DUBLIN, Nov. 25, 2020 /PRNewswire/ -- The "Global Biomaterials Market By Product (Implants, Valves, Joint Replacement, Contact Lenses and Others), By Material Type (Metallic, Natural, Ceramics, Polymeric, Living Cell and Tissue), By Type, By Application, By End User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Biomaterials Market is expected to register substantial rate of growth during the forecast period owing to factors like increasing geriatric population, rapidly growing healthcare sector and its wider use in various products and applications, such as contact lenses, skin repair, blood vessel prosthesis, gene transfer, drug delivery, and dental.

Biomaterials are artificially derived synthetic or natural materials which are used to interact with biological systems for medical purposes and treatments. They are often used in medical applications to augment or replace a natural function. The biomaterial market is anticipated to grow significantly during the next five years due to discoveries in tissue engineering, regenerative medicine, and more. They often are biodegradable, and some are bio-absorbable, meaning they are eliminated gradually from the body after fulfilling a function. Additionally, metals, ceramics, plastic, glass, and even living cells and tissue all can be used in creating a biomaterial. Moreover, heavy funding by government organizations for innovation of new products is creating new scope for the growth in biomaterials market. Rising prevalence of cardiovascular, neurological, & orthopedic disorders, coupled with increasing awareness regarding the advantages of biomaterials products is further driving the market. Furthermore, rising prevalence of cardiovascular, neurological, & orthopedic disorders around the world is anticipated to create major demand for biomaterials through 2025.

The Global Biomaterials Market is segmented based on product, material type, type, application, end-user, and region. Based on material type, the market is segmented into metallic, natural, ceramics, polymeric, living cell and tissue. The metallic biomaterials segment held lion's share in 2019 due to wide use of metals in the manufacturing of medical devices and their use in orthopedic procedures for bone support and replacement, as they are strong and resistant to fatigue degradation.

By region, North America dominates the biomaterials market owing to the initiatives undertaken by several public and private organizations in the region. Also, factors such as favorable government policies and presence of major market players made the region dominant in terms of revenue share in 2019. However, Asia-Pacific region is expected to register highest CAGR in the coming years due to a large population base in countries like India and China coupled with growing incidences of chronic diseases and rising awareness about biomaterials in the region.

Objective of the Study:

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Biomaterials Market

4. Executive Summary

5. Global Biomaterials Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Product (Implants, Valves, Joint Replacement, Contact Lenses and Others)
5.2.2. By Material Type (Metallic, Natural, Ceramics, Polymeric, Living Cell and Tissue)
5.2.3. By Type (Bioinert, Bioresorbable, Bio Tolerant and Bioactive)
5.2.4. By Application (Ophthalmology, Cardiovascular, Orthopedic, Wound Healing, Plastic Surgery, Neurology, Dental, Others)
5.2.5. By End User (Private Hospitals, Government Hospitals, Specialty Clinics)
5.2.6. By Company (2019)
5.2.7. By Region
5.3. Market Attractiveness Index

6. Asia-Pacific Biomaterials Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Material Type
6.2.2. By Application
6.2.3. By Country
6.3. Market Attractiveness Index
6.4. Asia-Pacific: Country Analysis
6.4.1. China Biomaterials Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Material Type
6.4.1.2.2. By Application
6.4.2. India Biomaterials Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Material Type
6.4.2.2.2. By Application
6.4.3. Japan Biomaterials Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Material Type
6.4.3.2.2. By Application
6.4.4. South Korea Biomaterials Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Material Type
6.4.4.2.2. By Application
6.4.5. Singapore Biomaterials Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Material Type
6.4.5.2.2. By Application
6.4.6. Australia Biomaterials Market Outlook
6.4.6.1. Market Size & Forecast
6.4.6.1.1. By Value
6.4.6.2. Market Share & Forecast
6.4.6.2.1. By Material Type
6.4.6.2.2. By Application

7. Europe Biomaterials Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Material Type
7.2.2. By Application
7.2.3. By Country
7.3. Market Attractiveness Index
7.4. Europe: Country Analysis
7.4.1. France Biomaterials Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Material Type
7.4.1.2.2. By Application
7.4.2. Germany Biomaterials Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Material Type
7.4.2.2.2. By Application
7.4.3. United Kingdom Biomaterials Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Material Type
7.4.3.2.2. By Application
7.4.4. Italy Biomaterials Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Material Type
7.4.4.2.2. By Application
7.4.4.2.3. By End User

8. North America Biomaterials Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Material Type
8.2.2. By Application
8.2.3. By Country
8.3. Market Attractiveness Index
8.4. North America: Country Analysis
8.4.1. United States Biomaterials Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Material Type
8.4.1.2.2. By Application
8.4.2. Mexico Biomaterials Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Material Type
8.4.2.2.2. By Application
8.4.3. Canada Biomaterials Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Material Type
8.4.3.2.2. By Application

9. South America Biomaterials Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Material Type
9.2.2. By Application
9.2.3. By Country
9.3. Market Attractiveness Index
9.4. South America: Country Analysis
9.4.1. Brazil Biomaterials Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Material Type
9.4.1.2.2. By Application
9.4.2. Argentina Biomaterials Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Material Type
9.4.2.2.2. By Application
9.4.3. Colombia Biomaterials Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Material Type
9.4.3.2.2. By Application

10. Middle East and Africa Biomaterials Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Material Type
10.2.2. By Application
10.2.3. By Country
10.3. Market Attractiveness Index
10.4. MEA: Country Analysis
10.4.1. South Africa Biomaterials Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Material Type
10.4.1.2.2. By Application
10.4.2. Saudi Arabia Biomaterials Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Material Type
10.4.2.2.2. By Application
10.4.3. UAE Biomaterials Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Material Type
10.4.3.2.2. By Application

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape
13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
13.2.1. Koninklijke DSM N.V.
13.2.2. Bayer AG
13.2.3. Corbion NV
13.2.4. Wright Medical Technology, Inc.
13.2.5. Zimmer Biomet Holdings, Inc.
13.2.6. Collagen Matrix, Inc.
13.2.7. Noble Biomaterials Inc
13.2.8. Covalon Technologies Ltd
13.2.9. Olympus corporation
13.2.10. Johnson & Johnson
13.2.11. Cook Medical
13.2.12. Smith and Nephew
13.2.13. Becton Dickinson
13.2.14. Medtronic
13.2.15. Angiodynamics

14. Strategic Recommendations

15. About Us & Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/j7yiqc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new...

at 01:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

17 avr 2024
Mentor Capital, Inc. , a classic energy company, in its 2023 10-K, reported cash of $0.10 per share with no net debt versus today's share price of $0.04 per share. During 2023, the Company announced that the theoretical cash breakup value of the...

17 avr 2024
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, declared today a cash distribution of Ps. 777.7 million (US$46.5 million), or Ps. 0.5892 per Certificado Bursátil Fiduciario Inmobiliario...

17 avr 2024
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, today reported results for the first quarter 2024. HIGHLIGHTS FROM THE QUARTER: Net effective rents on rollover were 47.7 percent.Period-end...



News published on and distributed by: